In a report released today, Benjamin Burnett from Stifel Nicolaus maintained a Hold rating on Fate Therapeutics (FATE – Research Report), with ...
In a report released today, Tore Svanberg from Stifel Nicolaus reiterated a Buy rating on Marvell (MRVL – Research Report), with a price target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback